Advertisement
Australia markets open in 3 hours 13 minutes
  • ALL ORDS

    8,083.10
    -35.20 (-0.43%)
     
  • AUD/USD

    0.6605
    -0.0016 (-0.25%)
     
  • ASX 200

    7,811.80
    -36.30 (-0.46%)
     
  • OIL

    77.06
    -0.51 (-0.66%)
     
  • GOLD

    2,330.60
    -62.30 (-2.60%)
     
  • Bitcoin AUD

    102,251.85
    -2,961.73 (-2.81%)
     
  • CMC Crypto 200

    1,457.81
    -44.85 (-2.98%)
     

Company News For May 13, 2024

  • Novavax, Inc. (NVAX) shares surged 98.7% after announcing a $1.2 billion deal with Sanofi (SNY) to commercialize a combined COVID-19 and flu vaccine.

  • Moderna, Inc. (MRNA) shares dropped 4.4% after the company announced that the Food and Drug Administration (FDA) postponed its approval decision for Moderna's respiratory syncytial virus (RSV) vaccine.

  • Shares of Genpact Limited (G) rose 3.6% after reporting first-quarter 2024 revenues of $1.13 billion, outpacing the Zacks Consensus Estimate of $1.11 billion.

  • IAMGOLD Corporation (IAG) shares increased 11.7% after reporting first-quarter 2024 adjusted earnings per share of $0.11, exceeding the Zacks Consensus Estimate of $0.2 per share.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Sanofi (SNY) : Free Stock Analysis Report

Moderna, Inc. (MRNA) : Free Stock Analysis Report

ADVERTISEMENT

Genpact Limited (G) : Free Stock Analysis Report

Novavax, Inc. (NVAX) : Free Stock Analysis Report

Iamgold Corporation (IAG) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research